Urinalysis Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Urinalysis market is segmented By Product Type (Instruments, Consumables), Test Type, Application, and Geography.

Urinalysis Market Snapshot

Urinalysis Test Market Size
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 7.5 %
Urinalysis Market Major Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Urinalysis market is expected to exibhit a growth of 7.5% CAGR during the forecast period. The higher burden of chronic diseases and rising adaptation of point of care testing is expected to be the major contributing factors for the market growth. Urinary tract infection refers to the infection in any part of the urinary system. According to the Therapeutic Advances in Urology, urinary tract infections are commonly found in the women with a global incidence of around 50% - 60% in adult women, in 2019. Furthermore, according to the study of Parasites and Vectors, 2019, which evaluated the Clinitek (manufactured by Siemens Healthineers) for its efficacy. Clinitek is a point-of-care testing that automatically checks the humidity exposure and other parameters. The results for this evaluation was observed that the device was enable to successfully detect the haematuria and nitrites. Hence, these factors are expected to fuel the growth of urinalysis market.

Scope of the Report

Urinalysis is a type of test which is performed for detecting disorders related to kidney, urinary tract infectionor diabetes. Urinalysis Market is segmented By Product Type, Test Type, Application and Geography.

By Product Type
Instruments
Automated Analyser
Semi-automated Analyzer
Point of Care Analyzer
Consumables
Reagents & Kits
Dipsticks
Disposables
By Test Type
Biochemical
Pregnancy & Fertility
Sediment
By Application
Disease Screening
Pregnancy & Fertility
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Automated Analysers Segment is Expected to Hold a Major Market Share in the Market

Automated analyzers segment is expected to hold a major market share in the urinalysis treatment owing to technological advancments in the product. For instance, in 2018, Beckman Coulter and Arkray Inc. patnered to develop iQ Urinalysis Workcell for urinalysis testing. It involves a morphology imaging system and a automated analyzer. Furthermore, according to the study published, in 2019, by Journal of Clinical Laboratory Analysis, the automated analyzers were found to be more efficient and effective for urinalysis.

Also, higher prevalence of diabetes is expected to boost up the demand for automated analyzers. According to International Diabetes Federation, in 2019, around 429.9 million people were diagnosed with diabetes. Hence, aforementioned factors are expected to propel the urinalysis market grwoth.

Urinalysis Test Market Growth

North America is Expected to Hold a Significant Share in the Market

North America is expected to hold a major market share in the global urinalysis market due to increasing aging population and higher prevalence of chronic kidney diseases. Chronic kidney disease is associated with the kidney failure. According to National Kidney Foundation, chronic kidney disease causes more death than breast cancer and prostate cancer. Currently, around 37 million people are affected with it. It is more prevalent in older population, affecting approximately 15% of the adult population. Hence, this emerges the need for proper diagnosis and treatment of chronic kidney diseases and thereby these factors are expected to boost the demand for urinalysis market.

Urinalysis Test Market Report

Competitive Landscape

Companies are taking strategic initiatives to grow their presence in the urinalysis market. For instance, in 2016, Sysmex launched UD-10 Fully-Automated Imaging for testing of sediment urinalysis. Currently the market is dominated by few players such as Cardinal Health Inc., Alere (Abbott Laboratories), Beckman Coulter Inc., Siemens Healthineers, Roche Diagnostics, Sysmex Corporation, Bio-Rad Laboratories Inc., Arkray Inc., Acon Laboratories Inc., and Becton, Dickinson and Company.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Burden of Chronic Kidney Disease

      2. 4.2.2 Rising Preference for Point of Care Testing

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulatory framework

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product Type

      1. 5.1.1 Instruments

        1. 5.1.1.1 Automated Analyser

        2. 5.1.1.2 Semi-automated Analyzer

        3. 5.1.1.3 Point of Care Analyzer

      2. 5.1.2 Consumables

        1. 5.1.2.1 Reagents & Kits

        2. 5.1.2.2 Dipsticks

        3. 5.1.2.3 Disposables

    2. 5.2 By Test Type

      1. 5.2.1 Biochemical

      2. 5.2.2 Pregnancy & Fertility

      3. 5.2.3 Sediment

    3. 5.3 By Application

      1. 5.3.1 Disease Screening

      2. 5.3.2 Pregnancy & Fertility

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories (Alere)

      2. 6.1.2 Acon Laboratories Inc.

      3. 6.1.3 Arkray Inc.

      4. 6.1.4 Beckman Coulter Inc.

      5. 6.1.5 Becton, Dickinson and Company

      6. 6.1.6 Bio-Rad Laboratories Inc.

      7. 6.1.7 Cardinal Health Inc.

      8. 6.1.8 Roche Diagnostics

      9. 6.1.9 Siemens Healthineers

      10. 6.1.10 Sysmex Corporation

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Urinalysis Market market is studied from 2018 - 2026.

The Urinalysis Market is growing at a CAGR of 7.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Cardinal Health Inc., Roche Diagnostics , Sysmex Corporation, Arkray Inc. , Beckman Coulter Inc. are the major companies operating in Urinalysis Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!